Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

Updates in endocrine therapy for metastatic breast cancer

Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor

Proposed treatment for patients with HER2-positive breast cancer

Cancers, Free Full-Text

Dysregulated Genes in Breast Cancer (Lecture) Flashcards

A: Breast cancer comprises four subtypes defined by the positive (+)

Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells - ScienceDirect

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer

IJMS, Free Full-Text

An emerging generation of endocrine therapies in breast cancer: a clinical perspective

Mechanisms of estrogen receptor (ER) actions and endocrine resistance

Breast Cancer and Hormone Receptor Positive Status - Moose and Doc

Hormone Receptor Status and Diagnosis in Breast Cancer

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer